Purpose of Study
The purpose of this study is to test the safety and effectiveness of 2 concentrations of NFX-179 gel compared with placebo gel in reducing the appearance of cutaneous neurofibromas (cNFs) in subjects with Neurofibromatosis Type 1 (NF1).
- Ages 18+
- Diagnosed with neurofibromatosis type 1
- Have 10 clinically diagnosed cNFs
- 2 cutaneous neurofibromas on face